Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016
SKU ID :GMD-10222372 | Published Date: 30-Jun-2016 | No. of pages: 1371Description
TOC
Table of Contents
Table of Contents 2
Introduction 10
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Overview 11
Therapeutics Development 12
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeutics under Development by Companies 14
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeutics under Investigation by Universities/Institutes 31
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Products Glance 34
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Products under Development by Companies 38
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Products under Investigation by Universities/Institutes 68
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Companies Involved in Therapeutics Development 72
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeutics Assessment 272
Drug Profiles 325
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Dormant Projects 1293
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Discontinued Products 1311
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Product Development Milestones 1317
Appendix 1327
Tables & Figures
List of Tables
Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), H1 2016 54
Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Comparative Analysis, H1 2016 55
Number of Products under Development by Companies, H1 2016 57
Number of Products under Development by Companies, H1 2016 (Contd..1) 58
Number of Products under Development by Companies, H1 2016 (Contd..2) 59
Number of Products under Development by Companies, H1 2016 (Contd..3) 60
Number of Products under Development by Companies, H1 2016 (Contd..4) 61
Number of Products under Development by Companies, H1 2016 (Contd..5) 62
Number of Products under Development by Companies, H1 2016 (Contd..6) 63
Number of Products under Development by Companies, H1 2016 (Contd..7) 64
Number of Products under Development by Companies, H1 2016 (Contd..8) 65
Number of Products under Development by Companies, H1 2016 (Contd..9) 66
Number of Products under Development by Companies, H1 2016 (Contd..10) 67
Number of Products under Development by Companies, H1 2016 (Contd..11) 68
Number of Products under Development by Companies, H1 2016 (Contd..12) 69
Number of Products under Development by Companies, H1 2016 (Contd..13) 70
Number of Products under Development by Companies, H1 2016 (Contd..14) 71
Number of Products under Development by Companies, H1 2016 (Contd..15) 72
Number of Products under Investigation by Universities/Institutes, H1 2016 73
Number of Products under Investigation by Universities/Institutes, H1 2016 (Contd..1) 74
Number of Products under Investigation by Universities/Institutes, H1 2016 (Contd..2) 75
Comparative Analysis by Late Stage Development, H1 2016 76
Comparative Analysis by Clinical Stage Development, H1 2016 77
Comparative Analysis by Early Stage Development, H1 2016 78
Comparative Analysis by Unknown Stage Development, H1 2016 79
Products under Development by Companies, H1 2016 80
Products under Development by Companies, H1 2016 (Contd..1) 81
Products under Development by Companies, H1 2016 (Contd..2) 82
Products under Development by Companies, H1 2016 (Contd..3) 83
Products under Development by Companies, H1 2016 (Contd..4) 84
Products under Development by Companies, H1 2016 (Contd..5) 85
Products under Development by Companies, H1 2016 (Contd..6) 86
Products under Development by Companies, H1 2016 (Contd..7) 87
Products under Development by Companies, H1 2016 (Contd..8) 88
Products under Development by Companies, H1 2016 (Contd..9) 89
Products under Development by Companies, H1 2016 (Contd..10) 90
Products under Development by Companies, H1 2016 (Contd..11) 91
Products under Development by Companies, H1 2016 (Contd..12) 92
Products under Development by Companies, H1 2016 (Contd..13) 93
Products under Development by Companies, H1 2016 (Contd..14) 94
Products under Development by Companies, H1 2016 (Contd..15) 95
Products under Development by Companies, H1 2016 (Contd..16) 96
Products under Development by Companies, H1 2016 (Contd..17) 97
Products under Development by Companies, H1 2016 (Contd..18) 98
Products under Development by Companies, H1 2016 (Contd..19) 99
Products under Development by Companies, H1 2016 (Contd..20) 100
Products under Development by Companies, H1 2016 (Contd..21) 101
Products under Development by Companies, H1 2016 (Contd..22) 102
Products under Development by Companies, H1 2016 (Contd..23) 103
Products under Development by Companies, H1 2016 (Contd..24) 104
Products under Development by Companies, H1 2016 (Contd..25) 105
Products under Development by Companies, H1 2016 (Contd..26) 106
Products under Development by Companies, H1 2016 (Contd..27) 107
Products under Development by Companies, H1 2016 (Contd..28) 108
Products under Development by Companies, H1 2016 (Contd..29) 109
Products under Investigation by Universities/Institutes, H1 2016 110
Products under Investigation by Universities/Institutes, H1 2016 (Contd..1) 111
Products under Investigation by Universities/Institutes, H1 2016 (Contd..2) 112
Products under Investigation by Universities/Institutes, H1 2016 (Contd..3) 113
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by 4SC AG, H1 2016 114
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AB Science SA, H1 2016 115
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AbbVie Inc., H1 2016 116
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Acetylon Pharmaceuticals, Inc., H1 2016 117
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Actinium Pharmaceuticals, Inc., H1 2016 118
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by ADC Therapeutics Sarl, H1 2016 119
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Advenchen Laboratories, LLC, H1 2016 120
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Aeglea BioTherapeutics, Inc., H1 2016 121
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Affichem SA, H1 2016 122
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Agios Pharmaceuticals, Inc., H1 2016 123
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AIMM Therapeutics B.V., H1 2016 124
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Akinion Pharmaceuticals AB, H1 2016 125
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Altor BioScience Corporation, H1 2016 126
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Amgen Inc., H1 2016 127
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Antigen Express, Inc., H1 2016 128
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Antisense Therapeutics Limited, H1 2016 129
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by APIM Therapeutics AS, H1 2016 130
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Aprea AB, H1 2016 131
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by arGEN-X BV, H1 2016 132
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Ariad Pharmaceuticals, Inc., H1 2016 133
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Arno Therapeutics, Inc., H1 2016 134
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Arog Pharmaceuticals, Inc., H1 2016 135
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Array BioPharma Inc., H1 2016 136
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Astellas Pharma Inc., H1 2016 137
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Asterias Biotherapeutics, Inc., H1 2016 138
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Astex Pharmaceuticals, Inc., H1 2016 139
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AstraZeneca Plc, H1 2016 140
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Atara Biotherapeutics, Inc., H1 2016 141
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Athenex, Inc., H1 2016 142
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Aurigene Discovery Technologies Limited, H1 2016 143
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by AVEO Pharmaceuticals, Inc., H1 2016 144
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bayer AG, H1 2016 145
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BCI Pharma, H1 2016 146
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bellicum Pharmaceuticals, Inc., H1 2016 147
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BerGenBio AS, H1 2016 148
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bio-Cancer Treatment International Limited, H1 2016 149
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bio-Path Holdings, Inc., H1 2016 150
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BioInvent International AB, H1 2016 151
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BioLineRx, Ltd., H1 2016 152
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by BioSight Ltd., H1 2016 153
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Blueprint Medicines Corporation, H1 2016 154
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Boehringer Ingelheim GmbH, H1 2016 155
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Boston Biomedical, Inc., H1 2016 156
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Bristol-Myers Squibb Company, H1 2016 157
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Calithera Biosciences, Inc., H1 2016 158
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cancer Therapeutics CRC Pty Ltd, H1 2016 159
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cantargia AB, H1 2016 160
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cantex Pharmaceuticals, Inc., H1 2016 161
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cascadian Therapeutics Inc, H1 2016 162
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celator Pharmaceuticals, Inc., H1 2016 163
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celgene Corporation, H1 2016 164
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cellceutix Corporation, H1 2016 165
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celldex Therapeutics, Inc., H1 2016 166
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cellectis S.A., H1 2016 167
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cellerant Therapeutics, Inc., H1 2016 168
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Celyad SA, H1 2016 169
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by CharlestonPharma LLC, H1 2016 170
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Constellation Pharmaceuticals, Inc., H1 2016 171
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by ConverGene, LLC, H1 2016 172
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cornerstone Pharmaceuticals, Inc., H1 2016 173
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Critical Outcome Technologies Inc., H1 2016 174
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by CrystalGenomics, Inc., H1 2016 175
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by CTI BioPharma Corp., H1 2016 176
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Cyclacel Pharmaceuticals, Inc., H1 2016 177
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Daiichi Sankyo Company, Limited, H1 2016 178
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by DC Prime B.V., H1 2016 179
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Debiopharm International SA , H1 2016 180
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Deciphera Pharmaceuticals, LLC, H1 2016 181
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by DiNonA Inc., H1 2016 182
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Eisai Co., Ltd., H1 2016 183
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Eli Lilly and Company, H1 2016 184
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by EntreChem, S.L., H1 2016 185
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by EpiZyme, Inc., H1 2016 186
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Erytech Pharma SA, H1 2016 187
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Esperance Pharmaceuticals, Inc., H1 2016 188
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Eureka Therapeutics, Inc., H1 2016 189
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Exelixis, Inc., H1 2016 190
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by F. Hoffmann-La Roche Ltd., H1 2016 191
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Fate Therapeutics, Inc., H1 2016 192
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by FORMA Therapeutics, Inc., H1 2016 193
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Formula Pharmaceuticals, Inc., H1 2016 194
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Fortress Biotech, Inc., H1 2016 195
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Forty Seven Inc., H1 2016 196
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Fujifilm Corporation, H1 2016 197
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Gadeta B.V., H1 2016 198
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Galen Limited, H1 2016 199
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Gamida Cell Ltd., H1 2016 200
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genentech, Inc., H1 2016 201
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genoscience Pharma, H1 2016 202
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genosco, H1 2016 203
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Genzyme Corporation, H1 2016 204
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Gilead Sciences, Inc., H1 2016 205
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by GlaxoSmithKline Plc, H1 2016 206
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by GlycoMimetics, Inc., H1 2016 207
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Golden Biotechnology Corp., H1 2016 208
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by H3 Biomedicine Inc., H1 2016 209
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2016 210
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by HEC Pharm Co., Ltd., H1 2016 211
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline by Huperion Sarl, H1 2016 212
List of Figures
Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), H1 2016 54
Number of Products under Development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Comparative Analysis, H1 2016 55
Number of Products under Development by Companies, H1 2016 56
Number of Products under Investigation by Universities/Institutes, H1 2016 73
Comparative Analysis by Late Stage Development, H1 2016 76
Comparative Analysis by Clinical Stage Development, H1 2016 77
Comparative Analysis by Early Stage Products, H1 2016 78
Assessment by Monotherapy Products, H1 2016 314
Assessment by Combination Products, H1 2016 315
Number of Products by Top 10 Targets, H1 2016 316
Number of Products by Stage and Top 10 Targets, H1 2016 316
Number of Products by Top 10 Mechanism of Actions, H1 2016 339
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 339
Number of Products by Top 10 Routes of Administration, H1 2016 363
Number of Products by Stage and Top 10 Routes of Administration, H1 2016 363
Number of Products by Top 10 Molecule Types, H1 2016 365
Number of Products by Stage and Top 10 Molecule Types, H1 2016 365
Companies
4SC AG
AB Science SA
AbbVie Inc.
Acetylon Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.
ADC Therapeutics Sarl
Advenchen Laboratories, LLC
Aeglea BioTherapeutics, Inc.
Affichem SA
Agios Pharmaceuticals, Inc.
AIMM Therapeutics B.V.
Akinion Pharmaceuticals AB
Altor BioScience Corporation
Amgen Inc.
Antigen Express, Inc.
Antisense Therapeutics Limited
APIM Therapeutics AS
Aprea AB
arGEN-X BV
Ariad Pharmaceuticals, Inc.
Arno Therapeutics, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astellas Pharma Inc.
Asterias Biotherapeutics, Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
Atara Biotherapeutics, Inc.
Athenex, Inc.
Aurigene Discovery Technologies Limited
AVEO Pharmaceuticals, Inc.
Bayer AG
BCI Pharma
Bellicum Pharmaceuticals, Inc.
BerGenBio AS
Bio-Cancer Treatment International Limited
Bio-Path Holdings, Inc.
BioInvent International AB
BioLineRx, Ltd.
BioSight Ltd.
Blueprint Medicines Corporation
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Calithera Biosciences, Inc.
Cancer Therapeutics CRC Pty Ltd
Cantargia AB
Cantex Pharmaceuticals, Inc.
Cascadian Therapeutics Inc
Celator Pharmaceuticals, Inc.
Celgene Corporation
Cellceutix Corporation
Celldex Therapeutics, Inc.
Cellectis S.A.
Cellerant Therapeutics, Inc.
Celyad SA
CharlestonPharma LLC
Constellation Pharmaceuticals, Inc.
ConverGene, LLC
Cornerstone Pharmaceuticals, Inc.
Critical Outcome Technologies Inc.
CrystalGenomics, Inc.
CTI BioPharma Corp.
Cyclacel Pharmaceuticals, Inc.
Daiichi Sankyo Company, Limited
DC Prime B.V.
Debiopharm International SA
Deciphera Pharmaceuticals, LLC
DiNonA Inc.
Eisai Co., Ltd.
Eli Lilly and Company
EntreChem, S.L.
EpiZyme, Inc.
Erytech Pharma SA
Esperance Pharmaceuticals, Inc.
Eureka Therapeutics, Inc.
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Fate Therapeutics, Inc.
FORMA Therapeutics, Inc.
Formula Pharmaceuticals, Inc.
Fortress Biotech, Inc.
Forty Seven Inc.
Fujifilm Corporation
Gadeta B.V.
Galen Limited
Gamida Cell Ltd.
Genentech, Inc.
Genoscience Pharma
Genosco
Genzyme Corporation
Gilead Sciences, Inc.
GlaxoSmithKline Plc
GlycoMimetics, Inc.
Golden Biotechnology Corp.
H3 Biomedicine Inc.
Hanmi Pharmaceuticals, Co. Ltd.
HEC Pharm Co., Ltd.
Huperion Sarl
Hybrigenics S.A.
Igenica Biotherapeutics, Inc.
Ignyta, Inc.
Immatics Biotechnologies GmbH
Immune Pharmaceuticals Inc.
Immune System Key Ltd.
ImmunGene, Inc.
ImmunoGen, Inc.
Incyte Corporation
Inflection Biosciences Limited
Interprotein Corporation
Jasco Pharmaceuticals, LLC.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Johnson & Johnson
Juno Therapeutics Inc.
JW Pharmaceutical Corporation
Kainos Medicine, Inc.
Karyopharm Therapeutics, Inc.
Kiadis Pharma B.V.
Kolltan Pharmaceuticals, Inc.
Komipharm International Co., Ltd.
Kyowa Hakko Kirin Co., Ltd.
Lead Discovery Center GmbH
Les Laboratoires Servier SAS
MacroGenics, Inc.
Mateon Therapeutics Inc
MaxCyte, Inc.
medac GmbH
MediGene AG
Medivation, Inc.
MEI Pharma, Inc.
Merck & Co., Inc.
Merus B.V.
Mesoblast Limited
Millennium Pharmaceuticals, Inc.
miRagen Therapeutics, Inc.
Mirna Therapeutics, Inc.
Moleculin Biotech, Inc.
MolMed S.p.A.
Nanovalent Pharmaceuticals Inc.
NantKwest, Inc.
Nemucore Medical Innovations, Inc.
Nerviano Medical Sciences S.r.l.
Neumedicines Inc.
Novartis AG
NuCana BioMed Limited
Omeros Corporation
OncoImmune, Inc.
Onconova Therapeutics, Inc.
Oncopeptides AB
OncoTartis, Inc.
OncoTherapy Science, Inc.
Ono Pharmaceutical Co., Ltd.
Otsuka Holdings Co., Ltd.
Oxford BioTherapeutics Ltd
Panther Biotechnology, Inc.
Pfizer Inc.
Pharma Mar, S.A.
Pharmedartis GmbH
Philogen S.p.A.
Phylogica Limited
Plexxikon Inc.
Polaris Pharmaceuticals, Inc.
Polyphor Ltd.
Resverlogix Corp.
Rich Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Seattle Genetics, Inc.
Sellas Inc.
Selvita S.A.
Senhwa Biosciences, Inc.
Shire Plc
SialoTec GmbH
Sigma-Tau S.p.A.
SOM Innovation Biotech SL
Sorrento Therapeutics, Inc.
Stemline Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Sunesis Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc.
SYNIMMUNE GmbH
Synta Pharmaceuticals Corp.
Syros Pharmaceuticals, Inc.
TaiGen Biotechnology Co., Ltd.
Takeda Pharmaceutical Company Limited
Targazyme, Inc.
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Theravectys SA
Toko Pharmaceutical Industries Co., Ltd.
Tolero Pharmaceuticals, Inc.
Tragara Pharmaceuticals, Inc.
Trillium Therapeutics Inc.
Verastem, Inc.
Vichem Chemie Research Ltd.
VioQuest Pharmaceuticals, Inc.
Viralytics Ltd.
Xencor, Inc.
Xenetic Biosciences (UK) Limited
ZIOPHARM Oncology, Inc.
- PRICE
-
$1500$7500